AAAAAA

   
Results: 1-14 |
Results: 14
Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: A retrospective analysis of the utility of cytomorphology and flow cytometry
Authors: Dong, HY Harris, NL Preffer, FI Pitman, MB
Citation: Hy. Dong et al., Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: A retrospective analysis of the utility of cytomorphology and flow cytometry, MOD PATHOL, 14(5), 2001, pp. 472-481
Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants
Authors: Eppich, HM Foxall, R Gaynor, K Dombkowski, D Miura, N Cheng, T Silva-Arrieta, S Evans, RH Mangano, JA Preffer, FI Scadden, DT
Citation: Hm. Eppich et al., Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants, NAT BIOTECH, 18(8), 2000, pp. 882-887
Accumulation of macrophages with dendritic cell characteristics in the pulmonary response to Listeria
Authors: Kradin, RL Sakamoto, H Preffer, FI Dombkowski, D Springer, KM Leary, CP
Citation: Rl. Kradin et al., Accumulation of macrophages with dendritic cell characteristics in the pulmonary response to Listeria, AM J R CRIT, 161(2), 2000, pp. 535-542
Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
Authors: Penson, RT Kronish, K Duan, Z Feller, AJ Stark, P Cook, SE Duska, LR Fuller, AF Goodman, AK Nikrui, N MacNeill, KM Matulonis, UA Preffer, FI Seiden, MV
Citation: Rt. Penson et al., Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel, INT J GYN C, 10(1), 2000, pp. 33-41
Regulatory role of mature B cells in a murine model of inflammatory bowel disease
Authors: Mizoguchi, E Mizoguchi, A Preffer, FI Bhan, AK
Citation: E. Mizoguchi et al., Regulatory role of mature B cells in a murine model of inflammatory bowel disease, INT IMMUNOL, 12(5), 2000, pp. 597-605
Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens
Authors: Treon, SP Shima, Y Grossbard, ML Preffer, FI Belch, AR Pilarski, LM Anderson, KC
Citation: Sp. Treon et al., Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens, ANN ONCOL, 11, 2000, pp. 107-111
A boy with vertebral compression fractures - Pre B- cell acute lymphoblastic leukemia (precursor B- lymphoblastic leukemia)
Authors: Shapiro, FD de Leval, L Bramson, RT Preffer, FI
Citation: Fd. Shapiro et al., A boy with vertebral compression fractures - Pre B- cell acute lymphoblastic leukemia (precursor B- lymphoblastic leukemia), N ENG J MED, 343(16), 2000, pp. 1168-1176
In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A0201-restricted CD8(+) T cells in patients with melanoma
Authors: Linette, GP Shankara, S Longerich, S Yang, SX Doll, R Nicolette, C Preffer, FI Roberts, BL Haluska, FG
Citation: Gp. Linette et al., In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A0201-restricted CD8(+) T cells in patients with melanoma, J IMMUNOL, 164(6), 2000, pp. 3402-3412
Myeloperoxidase detection by three-color flow cytometry in acute lymphoblastic leukemia - Reply
Authors: Nguyen, PL Preffer, FI Harris, NL
Citation: Pl. Nguyen et al., Myeloperoxidase detection by three-color flow cytometry in acute lymphoblastic leukemia - Reply, AM J CLIN P, 112(1), 1999, pp. 123-124
Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS
Authors: Masiakos, PT MacLaughlin, DT Maheswaran, S Teixeira, J Fuller, AF Shah, PC Kehas, DJ Kenneally, MK Dombkowski, DM Ha, TU Preffer, FI Donahoe, PK
Citation: Pt. Masiakos et al., Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS, CLIN CANC R, 5(11), 1999, pp. 3488-3499
Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy
Authors: Treon, SP Shima, Y Preffer, FI Doss, DS Ellman, L Schlossman, RL Grossbard, ML Belch, AR Pilarski, LM Anderson, KC
Citation: Sp. Treon et al., Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy, SEMIN ONCOL, 26(5), 1999, pp. 97-106
Transplacental transmission of natural-killer-cell lymphoma
Authors: Catlin, EA Roberts, JD Erana, R Preffer, FI Ferry, JA Kelliher, AS Atkins, L Weinstein, HJ
Citation: Ea. Catlin et al., Transplacental transmission of natural-killer-cell lymphoma, N ENG J MED, 341(2), 1999, pp. 85-91
Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression
Authors: Shen, HM Cheng, T Preffer, FI Dombkowski, D Tomasson, MH Golan, DE Yang, O Hofmann, W Sodroski, JG Luster, AD Scadden, DT
Citation: Hm. Shen et al., Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression, J VIROLOGY, 73(1), 1999, pp. 728-737
Mullerian-inhibiting substance type II receptor expression and function inpurified rat Leydig cells
Authors: Lee, MM Seah, CC Masiakos, PT Sottas, CM Preffer, FI Donahoe, PK Maclaughlin, DT Hardy, MP
Citation: Mm. Lee et al., Mullerian-inhibiting substance type II receptor expression and function inpurified rat Leydig cells, ENDOCRINOL, 140(6), 1999, pp. 2819-2827
Risultati: 1-14 |